292 related articles for article (PubMed ID: 29998375)
21. Dendritic cells in cancer immunotherapy.
Vulink A; Radford KJ; Melief C; Hart DN
Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
[TBL] [Abstract][Full Text] [Related]
22. λ-Carrageenan improves the antitumor effect of dendritic cellbased vaccine.
Li J; Aipire A; Li J; Zhu H; Wang Y; Guo W; Li X; Yang J; Liu C
Oncotarget; 2017 May; 8(18):29996-30007. PubMed ID: 28404904
[TBL] [Abstract][Full Text] [Related]
23. Potential approaches for more successful dendritic cell-based immunotherapy.
Chiang CL; Balint K; Coukos G; Kandalaft LE
Expert Opin Biol Ther; 2015 Apr; 15(4):569-82. PubMed ID: 25553913
[TBL] [Abstract][Full Text] [Related]
24. Modulation of antitumor responses by dendritic cells.
Vieweg J; Jackson A
Springer Semin Immunopathol; 2005 Jan; 26(3):329-41. PubMed ID: 15609005
[TBL] [Abstract][Full Text] [Related]
25. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
[TBL] [Abstract][Full Text] [Related]
26. Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment.
Vasaturo A; Verdoes M; de Vries J; Torensma R; Figdor CG
Immunobiology; 2015 Feb; 220(2):243-8. PubMed ID: 25466585
[TBL] [Abstract][Full Text] [Related]
27. The use of dendritic cells in cancer immunotherapy.
Schuler G; Schuler-Thurner B; Steinman RM
Curr Opin Immunol; 2003 Apr; 15(2):138-47. PubMed ID: 12633662
[TBL] [Abstract][Full Text] [Related]
28. Dendritic cell preparation for immunotherapeutic interventions.
Simon T; Fonteneau JF; Grégoire M
Immunotherapy; 2009 Mar; 1(2):289-302. PubMed ID: 20635946
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells as vectors for immunotherapy of cancer.
Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK
Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
[TBL] [Abstract][Full Text] [Related]
30. Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy.
Patente TA; Pinho MP; Oliveira AA; Evangelista GCM; Bergami-Santos PC; Barbuto JAM
Front Immunol; 2018; 9():3176. PubMed ID: 30719026
[TBL] [Abstract][Full Text] [Related]
31. Advances in dendritic cell-based vaccine of cancer.
Zhang X; Gordon JR; Xiang J
Cancer Biother Radiopharm; 2002 Dec; 17(6):601-19. PubMed ID: 12537664
[TBL] [Abstract][Full Text] [Related]
32. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
[TBL] [Abstract][Full Text] [Related]
33. Directing dendritic cell immunotherapy towards successful cancer treatment.
Sabado RL; Bhardwaj N
Immunotherapy; 2010 Jan; 2(1):37-56. PubMed ID: 20473346
[TBL] [Abstract][Full Text] [Related]
34. Combination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines.
Fecek RJ; Storkus WJ
Immunotherapy; 2016 Oct; 8(10):1205-18. PubMed ID: 27605069
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cells in cancer immunology and immunotherapy.
Wculek SK; Cueto FJ; Mujal AM; Melero I; Krummel MF; Sancho D
Nat Rev Immunol; 2020 Jan; 20(1):7-24. PubMed ID: 31467405
[TBL] [Abstract][Full Text] [Related]
36. Dendritic cells and immunity against cancer.
Palucka K; Ueno H; Fay J; Banchereau J
J Intern Med; 2011 Jan; 269(1):64-73. PubMed ID: 21158979
[TBL] [Abstract][Full Text] [Related]
37. Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion.
DeVito NC; Plebanek MP; Theivanthiran B; Hanks BA
Front Immunol; 2019; 10():2876. PubMed ID: 31921140
[TBL] [Abstract][Full Text] [Related]
38. Transendothelial migration (TEM) of in vitro generated dendritic cell vaccine in cancer immunotherapy.
Ashraf MU; Jeong Y; Roh SE; Bae YS
Arch Pharm Res; 2019 Jul; 42(7):582-590. PubMed ID: 30937843
[TBL] [Abstract][Full Text] [Related]
39. [Immunotherapeutic effects of beta-elemene combined with interleukin-23 gene-modified dendritic cells on murine pancreatic carcinoma].
Tan G; Wang ZY; Wang XG; Cheng L; Yin S
Ai Zheng; 2006 Sep; 25(9):1082-6. PubMed ID: 16965646
[TBL] [Abstract][Full Text] [Related]
40. IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination.
Llopiz D; Ruiz M; Infante S; Villanueva L; Silva L; Hervas-Stubbs S; Alignani D; Guruceaga E; Lasarte JJ; Sarobe P
Oncotarget; 2017 Jan; 8(2):2659-2671. PubMed ID: 27926522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
